Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

DEFINITY RT

PERFLUTREN

Standard Dose
13.04MG/2ML (6.52MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview DEFINITY RT is listed in Drugs@FDA under application 021064 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient PERFLUTREN Form and strength INJECTABLE;INTRAVENOUS - 13.04MG/2ML (6.52MG/ML) Sponsor LANTHEUS MEDCL Submission history Latest submission status date: 2024-03-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview DEFINITY RT is listed in Drugs@FDA under application 021064 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PERFLUTREN Form and strength INJECTABLE;INTRAVENOUS - 13.04MG/2ML (6.52MG/ML) Sponsor LANTHEUS MEDCL Submission history Latest submission status date: 2024-03-01 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.